{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1383388844595508481.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Nicholette D. Palmer"}],"foaf:familyName":[{"@value":"Palmer"}],"foaf:givenName":[{"@value":"Nicholette D."}]}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1363388844595508480","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1371/journal.pgen.1002150"},{"@type":"URI","@value":"http://dx.plos.org/10.1371/journal.pgen.1002150"}],"notation":[{"@value":"Differential Effects of MYH9 and APOL1 Risk Variants on FRMD3 Association with Diabetic ESRD in African Americans"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1371/journal.pgen.1002150_82EB26GokU0xt4V0JriaQlFHVcM"}]}